Why is Beryl Drugs falling/rising?

As of 07-Oct, Beryl Drugs Ltd is experiencing a decline in its stock price, currently at Rs 22.75, which reflects a decrease of Rs 1.24 or 5.17%. Today's price summary indicates that the stock has underperformed its sector by 5.48%, and it has fallen after three consecutive days of gains. The stock touched an intraday low of Rs 22, marking an 8.3% drop. Additionally, the delivery volume has decreased significantly, falling by 46.41% against the five-day average, suggesting a decline in investor participation. Over the longer term, the stock has seen a year-to-date decline of 37.07% and a one-year decline of 41.77%, indicating ongoing challenges.
In the broader market context, Beryl Drugs' short-term performance over the past week shows a gain of 2.29%, which slightly outpaces the Sensex's increase of 2.07%. However, the stock's longer-term performance contrasts sharply with the benchmark, as it has underperformed significantly over one month, one year, and year-to-date periods. This disparity highlights the stock's struggles relative to the overall market, contributing to its current downward trend. The lack of available positive or negative factors further complicates the outlook, as no specific catalysts for the stock's movement are identified.